Pharmacy Updates in COPD Treatment
Chronic Obstructive Pulmonary Disease (COPD) is a chronic lung disease that causes breathing to be difficult, and includes bronchitis and emphysema. COPD affects millions of Americans and is the third leading cause of death in the U.S., according to the American Lung Association.This Education Center is intended to provide the latest treatment breakthroughs, FDA approvals, changes in the standard of care, and more for pharmacists.
FDA Approves Breztri Aerosphere for Treatment of COPD
December 1, 2020
The FDA has approved Breztri Aerosphere as a maintenance treatment for COPD. The treatment is a combination of budesonide, glycopyrrolate, and formoterol fumarate...
High-dose Statins, Fibrates May Significantly Reduce COPD Risk In Patients With Hyperlipidemia
February 2, 2021Increase in the cumulative exposure of statins and fibrates may significantly reduce the risk of COPD among patients with hyperlipidemia when administered in high doses...
Screen COPD Patients With Worsening Lung Function For Pulmonary Embolism?
January 7, 2021About 6% of patients with chronic obstructive pulmonary disease (COPD) who are admitted to the hospital with worsening respiratory symptoms will have pulmonary embolism...
Study Examines Effect of Switching from Multi-Inhaler to Single-Inhaler for Patients with Severe COPD
November 9, 2020 A recent clinical trial looked at whether switching from non-extra fine to extra fine therapeutic particles can improve bronchodilation and ventilation for these patients...
HCP Education Shifts COPD Diagnosis Methods
November 1, 2020While spirometry remains the “gold standard” for diagnosing COPD, challenges associated with the testing method led researchers to look at ways to improve knowledge about the diagnosing process through a provider education program...
.jpg "Cancer Drugs Hold Promise for Halting COPD-Associated Lung Inflammation")
Cancer Drugs Hold Promise for Halting COPD-Associated Lung Inflammation
October 26, 2020Cancer drugs that use ErbB kinase inhibitors to hasten the death of neutrophil cells responsible for inflammation could soon be used to treat lung inflammation in patients with chronic obstructive pulmonary disease...
